Health Media Articles

Excerpts of Key Health Media Articles in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Water authorities across the US are systematically distorting water tests to downplay the amount of lead in samples. Water boards in cities including Detroit and Philadelphia, as well as the state of Rhode Island, have distorted tests by using methods deemed misleading by the Environment Protection Agency. The revelation comes as the growing crisis in Flint, Michigan, has prompted an emergency EPA order, the condemnation of Barack Obama and the resignation of a top agency official. “Gamed” tests help ensure that water utilities don’t breach federal lead and copper rules. Dr Yanna Lambrinidou, a Virginia Tech academic, has disclosed what she considers to be evidence of deceptive practices ... after she sat on an EPA taskforce that reviewed federal rules on lead and copper poisoning. The taskforce ended its work last year, shortly before the full extent of the city of Flint’s problems with smelly, brown water hit the headlines, with Lambrinidou criticising the final report for failing to step up protections. Several cities have advised residents to use questionable methods when conducting official tests for lead content. These include encouraging testers to run taps for several minutes to flush out lead from the pipes. Such methods have been criticized by the EPA for not providing accurate results. If the water was tested directly from lead pipes, up to 96 million Americans could be found to be drinking water with unsafe levels of lead.

Note: For more along these lines, see concise summaries of deeply revealing government corruption news articles from reliable major media sources.

Some Marketplace reports about vitamins and supplements published in November contained incorrect information, CBC has learned. Last fall, Marketplace commissioned lab testing for samples of fish oil, vitamin C and protein powder supplements to see if consumers are actually getting what they pay for. Based on those test results, Marketplace reported that Emergen-C and two protein powders: GNC Lean Shake 25 and Cytosport Muscle Milk failed to live up to label claims. However, subsequent re-testing of the samples has found that the lab results and analysis provided to Marketplace were incorrect, and that there is no evidence of problems with those products. The original lab tests were performed by an independent lab in Michigan, which is ISO-17025 accredited, registered with the U.S. Food and Drug Administration, and used by the supplement industry. The lab was recommended by Neil Thanedar, co-founder and CEO of LabDoor, a company that has products tested and makes those results public to help guide consumers about vitamins and supplements. CBC re-tested some of the products at other independent, accredited labs. None of them found problems with the samples. While Thanedar admits some of the lab results he provided to Marketplace were flawed, he was still unable to explain how the mistakes were made.

Note: Definitely something fishy going on here. For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

When does Big Pharma profiting become profiteering? This issue was the subject last month of a Senate Finance Committee investigation of pricing practices of Gilead Sciences Inc., a leading provider of hepatitis C medications. After examining 20,000 pages of internal company documents, looking at Medicaid data and interviewing health care experts, the authors concluded that the Foster City drugmaker “pursued a calculated scheme for pricing and marketing its hepatitis C drug based on one goal: maximizing revenue regardless of the human consequences.” With the hepatitis C virus affecting about 3 million people in the United States, the impact of Gilead’s pricing strategy is real, measurable - and devastating. With a 12-week course of Gilead’s Harvoni priced at nearly $100,000, taxpayer-funded Medicare Part D spent $4.6 billion on hepatitis C alone in the first half of 2015. When insurers refuse to pay for treatment, all but the wealthy are left at risk for cirrhosis, liver cancer and death. While anticipating record profits of $30 billion in 2015, Gilead virtually eliminated its medication assistance program. More than 90 percent of hepatitis C patients can achieve a cure with as little as one pill a day. But to realistically address this epidemic at current pricing levels would bankrupt our health care system. Pharmaceutical innovation holds great promise for the future of our health care system. But not if none of us can afford it.

Note: For more along these lines, see concise summaries of deeply revealing news articles about big pharma profiteering. Then read an in-depth essay titled "The Truth About Drug Companies" by acclaimed author Dr. Marcia Angell.

People rely on unbiased research to find out important statistics about all facets of nutrition. However, recent research from the Charles Perkins Centre at the University of Sydney suggests there is bias in industry-funded research studies ... the full extent of which is still unknown. [Professor Lisa] Bero and her team reviewed 775 reports in the medical literature ... to determine whether nutrition studies funded by the food industry were "associated with outcomes favourable to the sponsor". "Most of the studies only looked at the [author's interpretation] of the research. If it were industry sponsored, they were more likely to have a conclusion that favoured the industry sponsor," Bero said. This latest paper [follows] Bero's previous study which found nutrition studies funded by artificial sweetener companies are more likely to lead to favourable results. So, what happens if more industry sponsored nutrition studies are proven to be biased? "If you look at other areas where the effects of industry sponsorship have been shown, like in the pharmaceutical research area and the tobacco research area, people have actually applied more consistent quality criteria," Bero said. "You'd also want to try to make sure that all the data is being published. In the nutrition area they don't have things like clinical trial registries like they do for drug studies, for example. So if you have a study that's unfavourable or parts of it are unfavourable, it's hard to tell if ... all of it has gotten published. That's a huge bias in the pharmaceutical and tobacco studies."

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in the food system and in the scientific community.

A report commissioned by the College of Family Physicians of Canada to examine the relationship between doctors and the pharmaceutical industry is being criticized. The document ... was completed in 2013 and only released this month after a number of doctors challenged the college board to make it public. In one of its key findings, the report notes, "There have been instances in which marketing messages have been portrayed as education and health care and pharmaceutical industries have attempted in this way to influence physicians' behaviour or practices," it says. "Evidence suggests that there could also be significant influence on the behaviour of individuals who may be offered gifts or other forms of support, even when the recipients perceive neither obligation nor influence." The report makes 20 recommendations dealing with issues such as conflict of interest, financial relationships, marketing and other relationships with the pharmaceutical and health care industries. But they don't prevent a doctor with ties to the pharmaceutical industry from serving in leadership positions, sponsoring certain events, or even from contributing to an "unrestricted" education fund. Alan Cassels, a drug policy researcher at the University of Victoria, is critical of the college for sitting on the report as long as it did. He suspects the college held it back because it's "pretty embarrassing."

Note: For more along these lines, see concise summaries of deeply revealing news articles about the corruption of science and big pharma profiteering. Then read an in-depth essay titled "The Truth About Drug Companies" by acclaimed author Dr. Marcia Angell.

The Campbell Soup Company may become the first major U.S. food company to list genetically modified organisms, or GMOs, in its ingredients lists nationwide as it threw its weight behind a national labeling standard. The company announced its support on Thursday for federal regulation of GMO standards, noting it is in favor of federal legislation that would allow the U.S. Food and Drug Administration and the U.S. Department of Agriculture to regulate which foods can be labeled GMOs. The company's support for federal legislation comes as Vermont prepares to implement the Vermont Genetically Engineered Food Labeling Act, which would require a GMO label on food by July 1, 2016, if the food is "entirely or partially produced with genetic engineering." Campbell posted an example of that label on its website and said it was preparing to expand the GMO labeling nationwide even without federal regulations, but to do so would need guidance from the FDA and USDA. The company estimates the new labels could be implemented in approximately 12 to 18 months after it gets guidance from the federal agencies. There is currently no federal standard for what food would constitute a GMO, unlike a food item that is deemed USDA Organic. The World Health Organization defines a GMO as "foods derived from organisms whose genetic material (DNA) has been modified in a way that does not occur naturally, e.g. through the introduction of a gene from a different organism."

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

The phrase “cancer screening saves lives” is ... familiar to most consumers of public service announcements. But that advice may be misleading. The ubiquitous adage ... fails to take into account deaths linked to factors related to the screening itself. For example, prostate cancer screening is known to return “numerous” false positives, writes Vinay Prasad, an assistant professor at Oregon Health and Science University, and contributes to over 1 million prostate biopsies a year. The procedure is “associated with serious harms, including admission to hospital and death.” What’s more, men diagnosed with prostate cancer are “more likely to have a heart attack or commit suicide in the year after diagnosis,” he writes. A similar case can be made for breast cancer screening. Fully 60 percent of women who get regular mammograms for 10 years have been handed a false positive result at some point. Being told you have breast cancer - even if it turns out that the test result was incorrect - has been associated with “psychosocial distress as great as a breast cancer diagnosis.” A massive study of 90,000 women over 25 years found that the regular screening did not change the women’s death rates. In fact, if anything, the screenings harmed some women: Out of every five cancers detected with the technology and treated, one was “not a threat to the woman’s health and did not need treatment such as chemotherapy, surgery or radiation,” all of which can cause serious side effects.

Note: Read more about routine over-diagnosis and unnecessary treatment of cancer in this New York Times article. And learn about the promising cancer research that has been largely suppressed by the medical-industrial complex. For more, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

Just months before Rob Bilott made partner at Taft Stettinius & Hollister, he received a call on his direct line from a cattle farmer. The farmer, Wilbur Tennant of Parkersburg, W.Va., said that his cows were dying left and right. He believed that the DuPont chemical company, which until recently operated a site in Parkersburg that is more than 35 times the size of the Pentagon, was responsible. Tennant had tried to seek help locally, he said, but DuPont just about owned the entire town. He had been spurned not only by Parkersburg’s lawyers but also by its politicians, journalists, doctors and veterinarians. Bilott decided right away to take the Tennant case, [and] filed a federal suit against DuPont in the summer of 1999. Dozens of boxes containing thousands of unorganized documents began to arrive at Taft’s headquarters: private internal correspondence, medical and health reports and confidential studies conducted by DuPont scientists. The story that Bilott began to see ... was astounding in its breadth, specificity and sheer brazenness. DuPont was nothing like the [other chemical] corporations he had represented at Taft. "DuPont had for decades been actively trying to conceal their actions. They knew this stuff was harmful, and they put it in the water anyway. These were bad facts." He had seen what the ... tainted drinking water had done to [the Tennants'] cattle. What was it doing to the tens of thousands of people in the areas around Parkersburg who drank it daily from their taps?

Note: Read the complete, detailed account of the lawsuit that exposed DuPont's massively harmful criminality at the link above. Read more about the thousands of people DuPont knowingly poisoned in this article. For more along these lines, see concise summaries of deeply revealing corporate corruption news articles from reliable major media sources.

Alex Hummell says few dentists seem worried enough about invisible, odorless mercury to take the kinds of precautions needed to prevent everyday exposures. As the head of a ... firm that sells sophisticated equipment to gauge airborne levels of highly toxic mercury at industrial sites worldwide, Hummell has watched manufacturers of all sorts put their employees through strict training programs in which they don special equipment to avoid even tiny exposures. Then he walks into dental clinics and is dumbfounded. On numerous occasions, he said, he has detected mercury levels in dental offices that were two to three times the average workday exposure limit of 100 micrograms per cubic meter set by the Occupational Safety and Health Administration, but patients and the staff were wearing little or no protective equipment. “I’ve seen in dental offices what would make these other offices have to shut down,” said Hummell. “They would be closing their doors and getting respirators on.” Instead, he said, “there are kids running around everywhere. It’s nuts. It’s the exact same toxin, and it’s being treated totally differently.” Several years ago, Hummell said, he set up a booth at a regional dental conference in Denver to demonstrate how his equipment could pick up rising mercury levels with a mere gentle brushing of a filling in an old tooth.

Note: For more on risks of mercury in fillings, see this mercola.com article. For more, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

About 8 percent of Americans experience PTSD; for veterans, that number is 30 percent. Treatment is notoriously difficult, but people could find relief in an unusual form: psychedelic drugs. MDMA - found in molly and ecstasy - earned a bad rap in the 1990s as ravers’ drug of choice. But psychotherapists are coming to value the way it increases empathy while decreasing fear and defensiveness. “MDMA gives people the ability to revisit an event that’s still painful without being overwhelmed,” says psychiatrist Michael Mithoefer. Following a recent MDMA trial, 83 percent of his treatment-resistant participants no longer showed symptoms of PTSD. In one study, Mithoefer worked with a New York City firefighter post-9/11. The subject had tried treatment before. While undergoing a popular method that uses eye movement to reprocess a trauma, he’d been so overcome that he ripped a sink off the wall. MDMA, however, worked. “It wasn’t easy for him,” Mithoefer says. “But our sink is still attached.” MDMA isn’t a one-trick pony either; it can treat end-of-life anxiety and alcoholism, and it’s not addictive. “We’re talking about the rise of a whole field of medicine,” says Rick Doblin, founder of the nonprofit Multidisciplinary Association for Psychedelic Studies, which is running a handful of MDMA trials, including Mithoefer’s. Doblin thinks the FDA will greenlight the drug for mainstream use by 2021.

Note: While the war on drugs has been called a "trillion dollar failure", the healing potentials of mind altering drugs are starting to be investigated more openly.

Dr. Nav Persaud, a family doctor in Toronto, asked and received thousands of pages of documents from Health Canada, and what he saw made him question the effectiveness of a popular morning sickness drug. But he can't talk about it, because Health Canada forced him to sign a confidentiality agreement, and threatened him with legal action if he makes the data public. Matthew Herder, [a] health law associate professor ... is calling on other doctors, researchers and journalists to bombard Ottawa with their own demands for drug industry data, using [a] new legislative lever written into ... the Protecting Canadians from Unsafe Drugs Act, which was passed late last year. Today, in the Canadian Medical Association Journal, Herder is urging Canadians to use the clause [to request] data that has long been protected by a wall of bureaucratic and corporate secrecy. The European Medicines Agency has started publishing all of the clinical reports submitted as part of drug marketing authorization applications - the same material Health Canada refuses to disclose. Almost half of the drug trials remain secret. [In the US], one group looked at 12 antidepressants, comparing the published studies with the internal FDA assessments. 94 per cent of the published studies were positive, compared to 51 per cent when they included all of the studies assessed by the FDA. The authors concluded that without seeing all the data, drug effectiveness can be exaggerated, leading doctors and patients to assume the medications work better than they do.

Note: For more along these lines, see concise summaries of deeply revealing news articles about government corruption and big pharma profiteering. Then read an in-depth essay titled "The Truth About Drug Companies" by acclaimed author Dr. Marcia Angell.

A judge ruled on Thursday that the New York City health department could not require young children to be vaccinated for the flu to attend city-licensed preschools and day care centers, striking down one of the more ambitious public health initiatives of the Bloomberg administration. Justice Manuel J. Mendez ... said the city could not add influenza to the list of diseases requiring immunization without action by the State Legislature. The mandate ... was scheduled to take effect in January. It required children between the ages of 6 months and 59 months to be vaccinated by shot or mist. The measure was approved unanimously by the Board of Health. But the proposal soon met fierce opposition, with many parents resisting and saying that their doctors told them the vaccine was not needed. The court ruling did not delve into the debate about vaccines. Michelle Carroll, 44, one of the plaintiffs in the suit and the mother of a 4-year-old girl, said the ruling was a victory for parents. “It’s important for people to remember that vaccines are drugs and just like any other drug, not every vaccine is going to be right for every single child,” Ms. Carroll said. The ruling was important, she said, because it left “the decision about whether or not to vaccinate our smallest, youngest, most vulnerable citizens” with pediatricians and parents.

Note: According to this NPR article, last year "the vaccine was only about 13 percent effective against the main strain." Could it be that we are being tricked into believing these vaccines a much more effective than they really are? Remember that big Pharma makes big profits from vaccines. For more, see this mercola.com article. For more along these lines, see concise summaries of deeply revealing vaccine controversy news articles from reliable major media sources.

With cellphone batteries typically lasting about a day because battery technology hasn’t kept pace with the ever-increasing power of many feature-rich phones, reaching for a cumbersome charger is a necessary chore. A new standard for wireless charging that’s becoming increasingly prevalent in furniture, cars, and some airport lounges and hotels wants to change that. The concept behind the chargers is straightforward - a base plugged into an electrical outlet emits a constantly-varying magnetic field, which causes a receiver in the device to vibrate, powering the battery and allowing it to charge. So far, more than 200 companies - including Microsoft, Samsung, LG Electronics, Verizon, Sanyo, and Phillips - have agreed to use a standard for the chargers called Qi. The market for wireless chargers has been growing steadily, with companies shipping 55 million devices that charged wirelessly in 2014, which grew to an expected 160 million this year, or $1.7 billion in sales. Since the technology is relatively new, there are some catches - Apple’s iPhone doesn’t natively support wireless charging, for example. Carmakers are taking notice of the technology, with Toyota offering wireless charging in its popular Camry and Toyota models and in Lexus cars, while BMW and Audi have begun offering it in some vehicles. Wireless charging continues to be adopted for use with more devices at home, at work, and in the car.

Note: The wireless products industry funds studies that downplay health risks associated with wireless technologies.

Abdel Gawad Ellabbad knows exactly how he was infected with hepatitis C. As a schoolboy in this Nile Delta rice-farming village, his class marched to the local clinic every month for injections against schistosomiasis, a parasitic disease spread by water snails. Six million Egyptians were infected with hepatitis C by unsterile needles during the country’s decades-long fight against schistosomiasis. The virus spread insidiously; today, at least 10 percent of Egyptians, nearly nine million people, are chronically infected, the highest rate in the world. But a grand experiment unfolding across the country may change all that. Pharmaceutical companies are testing ... a complicated deal to sell hepatitis drugs at a fraction of their usual cost. If [successful] the arrangement in Egypt may serve as a blueprint not just for curing hepatitis around the world, but also for providing other cutting-edge medicines to citizens in poor countries who could never afford them. The experiment here is about a year old and, while still fragile, appears to be headed for success. Mr. Ellabbad, for one, was finally cured of hepatitis this spring. An air-conditioning repairman, he took a three-month regimen that included sofosbuvir, first of the new generation of miracle drugs. The pills would have cost more than $84,000 in the United States. He got them free from the Egyptian government, which paid about $900. “Before, I felt like I was dying,” he said. “Now I feel like I’ve never felt before. Like I’m 35 again.”

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

Women who took antidepressants in the last six months of pregnancy were 87% more likely to have a child later diagnosed with autism. Doctors saw no increase in autism rates in women who took medication for depression in the first three months of pregnancy, according to [a new] study, published online Monday in JAMA Pediatrics. In the U.S., about 2.2% of children ages 3 to 17 - about one in 45 - have autism, according to the Center for Disease Control and Prevention's National Health Interview Survey, conducted in 2014. Women who took a specific type of antidepressants, called selective serotonin re-uptake inhibitors, or SSRIs, had more than double the risk of having a child with autism. Women who took more than one medication for depression ... were four times as likely to have a child with autism. The new study is ... part of a growing body of research that suggests that the events that cause autism largely occur before birth. Studies have found that children are at higher risk for autism, for example, if they are born early or very small. Children are also at higher risk if they are in medical distress during delivery; if they have older mothers or fathers; or if they are born less than a year after an older sibling.

Note: For more along these lines, see concise summaries of deeply revealing health news articles from reliable major media sources. Then explore the excellent, reliable resources provided in our Health Information Center.

A panel of scientists is disputing a World Health Organization report published earlier this year that concluded glyphosate, the world's most widely used weed killer and main ingredient in Monsanto Co's Roundup herbicide, is probably carcinogenic to humans. The 16-member panel, assembled by Intertek Scientific & Regulatory Consultancy, will present its findings to the annual meeting of the Society for Risk Analysis on Monday, aiming to publish the study at a later date after peer review. Monsanto paid Intertek for the panel's work. Concerns about glyphosate on food have been a hot topic of debate in the United States recently and contributed to the passage in Vermont last year of the country's first mandatory labeling law for foods that are genetically modified. Critics say that industry-linked scientists are downplaying the risk to human health and trying to discredit the IARC report by casting doubt on some of the scientific studies that it reviewed. Ten of the 16 scientists on the Intertek panel have been consultants for Monsanto in the past and two others are former Monsanto employees.

Note: Read an informative article titled "Monsanto Charged With Crimes Against Humanity" on mercola.com. Read how the EPA used industry studies while ignoring independent studies to declare Roundup safe. For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

The new movie Consumed tackles the controversial world of Genetically Modified Organisms (GMOs) in unprecedented fashion, offering insight into their risks. Its message could not be more timely in the wake of the recent news that the Food and Drug Administration has approved the first genetically engineered salmon for human consumption. The fish, like all genetically engineered ingredients in this country, will not be labeled, leaving American consumers in the dark. Like many food and environmental safety activists around the world, Im outraged. The biotech industry and the FDA have hijacked not only our basic rights as consumers, but also our fundamental human rights in the face of corporate monopolization of our food supply. They are jeopardizing our health and the environment more than ever before. In detailed comments submitted to the FDA, Michael Hansen, senior scientist at Consumers Union, argues the FDA review process was based on sloppy science and the genetically engineered salmon could pose many risks. Because FDAs assessment is inadequate, we are particularly concerned that this salmon may pose an increased risk of severe, even life-threatening allergic reactions, he writes. The majority of Americans ... believe they have a fundamental right to know what is in their food. A 2013 New York Times poll found that 93% of Americans want GMOs to be labeled. More than 60 countries label GMOs, and in some cases even ban them, but the U.S. still does not.

Note: Read an excellent mercola.com article titled "GMO cookie is crumbling." For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

In approving genetically engineered salmon as safe to eat and safe for the environment, the Food and Drug Administration rejected petitions from environmental and food safety groups asking that companies selling this salmon be required to label it as genetically engineered. Congress should overturn that decision. The salmon, made by AquaBounty Technologies of Maynard, Mass., has genes inserted that allow it to grow to market size twice as fast as wild salmon. At least one consumer group has announced plans to sue the F.D.A. to overturn its approval of the engineered salmon. Some leading grocery chains, responding to consumer concerns, have said they won’t sell the genetically engineered salmon. The F.D.A. said there is no reason to mandate labeling because there is no material difference between engineered and natural fish. But the value of that information should be left to consumers to decide. Vermont enacted a law last year that will require labeling of genetically engineered foods starting next July unless a suit filed in June 2014 by four industry trade groups derails it. Other states with strong consumer movements may try to follow. The House passed a bill on July 23, 2015, that would pre-empt states from requiring such labeling, and industry groups are pressing the Senate to attach similar language as a rider to an omnibus spending bill. The Senate should rebuff that tactic and allow states to adopt mandatory labeling laws if they wish.

Note: For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

Dow AgroSciences, which sells seeds and pesticides to farmers, made contradictory claims to different parts of the U.S. government about its latest herbicide. The Environmental Protection Agency just found out, and now wants to cancel Dow's legal right to sell the product. The herbicide, which the company calls Enlist Duo, is a mixture of two chemicals: glyphosate (also known as Roundup) and 2,4-D. It's Dow's answer to the growing problem of weeds that are resistant to glyphosate, which has become the weed-killing weapon of choice for farmers across the country. The new formulation is intended to work hand-in-hand with a new generation of corn and soybean seeds that are genetically engineered to tolerate sprays of both herbicides. When Dow applied for permission to sell Enlist Duo in 2011, it told the EPA that this mixture of glyphosate and 2,4-D is no more toxic than the two chemicals are, if considered separately. The EPA ... approved the new herbicide just over a year ago, [yet later] discovered that Dow had been telling the U.S. Patent and Trademark Office a different story. Dow's patent application for Enlist Duo claims that this mixture of chemicals does, in fact, offer farmers something new: "synergistic herbicidal weed control." Last month, the EPA asked Dow to explain these synergistic effects. On Nov. 9, the company responded with what the EPA calls "extensive information." The EPA, after taking a look at the new information, decided to ask the court for a chance to reverse its approval of Enlist Duo.

Note: Read an excellent mercola.com article titled "GMO cookie is crumbling." For more along these lines, see concise summaries of deeply revealing news articles about the corruption of science and the controversy surrounding GMOs.

The world’s biggest animal “cloning factory” is due to open in China, producing one million calves a year, sniffer dogs and even genetic copies of the family pet. The center may cause alarm in Europe, where the cloning of animals for farming was banned in September due to animal welfare considerations. But Xu Xiaochun, chairman of Chinese biotechnology company BoyaLife that is backing the facility, dismissed such concerns. Interest in agricultural biotechnology has been rapidly increasing in China, where [beef prices] are said to have tripled from 2000 to 2013. Mr Xu said his new facility will clone racehorses and a handful of dogs for people with “emotional ties” to their pets, but its main focus was producing cattle. However, he appeared to be more excited about its ability to churn out sniffer dogs. “The dog has to be smart and obedient, strong, sensitive," he said. The factory, which will include a 15,000 square metre laboratory, an animal centre, a gene bank and an exhibition hall ... is due to open in the first half of next year. BoyaLife will operate the facility with its South Korean partner, Sooam Biotech, that runs a centre that can clone dogs for customers willing to pay $100,000 (Ł66,000), and has already produced more than 550 puppies. The new facility will initially produce 100,000 cattle embryos a year, eventually increasing to one million.

Note: For more along these lines, see concise summaries of deeply revealing GMO news articles from reliable major media sources.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.